We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CVS Health Corporation | NYSE:CVS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.81 | 1.47% | 55.96 | 56.43 | 54.96 | 55.22 | 23,942,832 | 01:00:00 |
Date of Report (Date of earliest event reported): | May 11, 2022 |
Delaware | 001-01011 | 05-0494040 | ||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, par value $0.01 per share | CVS | New York Stock Exchange |
Emerging growth company | ☐ | ||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Item | For | Against | Abstained | Broker Non-Votes | |||||||||||||
1. | The election, for one-year terms, of persons nominated for election as directors of the Company, as set forth in the Company’s Proxy Statement, was approved by the following votes: | ||||||||||||||||
Fernando Aguirre | 980,147,086 | 4,942,589 | 2,361,204 | 152,337,594 | |||||||||||||
C. David Brown II | 921,004,907 | 64,110,649 | 2,335,323 | 152,337,594 | |||||||||||||
Alecia A. DeCoudreaux | 981,033,116 | 4,151,581 | 2,266,182 | 152,337,594 | |||||||||||||
Nancy-Ann M. DeParle | 972,420,338 | 12,943,153 | 2,087,388 | 152,337,594 | |||||||||||||
Roger N. Farah | 969,456,061 | 15,758,278 | 2,236,540 | 152,337,594 | |||||||||||||
Anne M. Finucane | 961,929,331 | 23,425,711 | 2,095,837 | 152,337,594 | |||||||||||||
Edward J. Ludwig | 974,606,439 | 10,568,872 | 2,275,568 | 152,337,594 | |||||||||||||
Karen S. Lynch | 978,273,848 | 7,721,357 | 1,455,674 | 152,337,594 | |||||||||||||
Jean-Pierre Millon | 953,549,562 | 31,648,123 | 2,253,194 | 152,337,594 | |||||||||||||
Mary L. Schapiro | 981,394,995 | 3,978,425 | 2,077,459 | 152,337,594 | |||||||||||||
William C. Weldon | 972,634,619 | 12,527,031 | 2,289,229 | 152,337,594 | |||||||||||||
2. | Company proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2022, as set forth in the Company’s Proxy Statement, was approved by the following vote: | 1,116,442,556 | 20,830,100 | 2,515,817 | None | ||||||||||||
3. | Company proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers, as set forth in the Company’s Proxy Statement, was approved by the following vote: | 903,024,507 | 80,791,141 | 3,635,231 | 152,337,594 | ||||||||||||
4. | Stockholder proposal for reducing the Company’s ownership threshold to request a special stockholder meeting, as set forth in the Company’s Proxy Statement, was not approved by the following vote: | 417,733,556 | 566,063,103 | 3,654,220 | 152,337,594 | ||||||||||||
5. | Stockholder proposal regarding the Company’s independent Board Chair, as set forth in the Company’s Proxy Statement, was not approved by the following vote: | 210,689,771 | 767,744,358 | 9,016,750 | 152,337,594 | ||||||||||||
6. | Stockholder proposal on a civil rights and non-discrimination audit focused on “non-diverse” employees, as set forth in the Company’s Proxy Statement, was not approved by the following vote: | 15,848,267 | 956,586,591 | 15,016,021 | 152,337,594 | ||||||||||||
7. | Stockholder proposal requesting paid sick leave for all employees, as set forth in the Company’s Proxy Statement, was not approved by the following vote: | 255,627,021 | 719,860,486 | 11,963,372 | 152,337,594 | ||||||||||||
8. | Stockholder proposal regarding a report on the public health costs of the Company’s food business to diversified portfolios, as set forth in the Company’s Proxy Statement, was not approved by the following vote: | 116,708,035 | 854,020,238 | 16,722,606 | 152,337,594 |
104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. |
CVS HEALTH CORPORATION | ||||||||
Date: May 16, 2022 | By: | /s/ Colleen M. McIntosh | ||||||
Colleen M. McIntosh | ||||||||
Senior Vice President, Corporate Secretary | ||||||||
and Chief Governance Officer | ||||||||
1 Year CVS Health Chart |
1 Month CVS Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions